Literature DB >> 18254127

Impact of mis-specification of the treatment model on estimates from a marginal structural model.

Geneviève Lefebvre1, Joseph A C Delaney, Robert W Platt.   

Abstract

Inverse probability of treatment weighted (IPTW) estimation for marginal structural models (MSMs) requires the specification of a nuisance model describing the conditional relationship between treatment allocation and confounders. However, there is still limited information on the best strategy for building these treatment models in practice. We developed a series of simulations to systematically determine the effect of including different types of candidate variables in such models. We explored the performance of IPTW estimators across several scenarios of increasing complexity, including one designed to mimic the complexity typically seen in large pharmacoepidemiologic studies.Our results show that including pure predictors of treatment (i.e. not confounders) in treatment models can lead to estimators that are biased and highly variable, particularly in the context of small samples. The bias and mean-squared error of the MSM-based IPTW estimator increase as the complexity of the problem increases. The performance of the estimator is improved by either increasing the sample size or using only variables related to the outcome to develop the treatment model. Estimates of treatment effect based on the true model for the probability of treatment are asymptotically unbiased.We recommend including only pure risk factors and confounders in the treatment model when developing an IPTW-based MSM. 2008 John Wiley & Sons, Ltd

Entities:  

Mesh:

Year:  2008        PMID: 18254127     DOI: 10.1002/sim.3200

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  28 in total

1.  The positivity assumption and marginal structural models: the example of warfarin use and risk of bleeding.

Authors:  Robert William Platt; Joseph Austin Christopher Delaney; Samy Suissa
Journal:  Eur J Epidemiol       Date:  2011-12-08       Impact factor: 8.082

2.  Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.

Authors:  Michael McCulloch; Michael Broffman; Mark van der Laan; Alan Hubbard; Lawrence Kushi; Donald I Abrams; Jin Gao; John M Colford
Journal:  Integr Cancer Ther       Date:  2011-09-30       Impact factor: 3.279

3.  Marginal Structural Models: unbiased estimation for longitudinal studies.

Authors:  Erica E M Moodie; D A Stephens
Journal:  Int J Public Health       Date:  2010-10-08       Impact factor: 3.380

4.  Time-modified confounding.

Authors:  Robert W Platt; Enrique F Schisterman; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2009-08-12       Impact factor: 4.897

Review 5.  Application of marginal structural models in pharmacoepidemiologic studies: a systematic review.

Authors:  Shibing Yang; Charles B Eaton; Juan Lu; Kate L Lapane
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-01-24       Impact factor: 2.890

6.  Impact of sedation and analgesia during noninvasive positive pressure ventilation on outcome: a marginal structural model causal analysis.

Authors:  Alfonso Muriel; Oscar Peñuelas; Fernando Frutos-Vivar; Alejandro C Arroliga; Victor Abraira; Arnaud W Thille; Laurent Brochard; Nicolás Nin; Andrew R Davies; Pravin Amin; Bin Du; Konstantinos Raymondos; Fernando Rios; Damian A Violi; Salvatore M Maggiore; Marco Antonio Soares; Marco González; Fekri Abroug; Hans-Henrik Bülow; Javier Hurtado; Michael A Kuiper; Rui P Moreno; Amine Ali Zeggwagh; Asisclo J Villagómez; Manuel Jibaja; Luis Soto; Gabriel D'Empaire; Dimitrios Matamis; Younsuck Koh; Antonio Anzueto; Niall D Ferguson; Andrés Esteban
Journal:  Intensive Care Med       Date:  2015-05-14       Impact factor: 17.440

7.  Improving propensity score estimators' robustness to model misspecification using super learner.

Authors:  Romain Pirracchio; Maya L Petersen; Mark van der Laan
Journal:  Am J Epidemiol       Date:  2014-12-16       Impact factor: 4.897

8.  Effect Estimation in Point-Exposure Studies with Binary Outcomes and High-Dimensional Covariate Data - A Comparison of Targeted Maximum Likelihood Estimation and Inverse Probability of Treatment Weighting.

Authors:  Menglan Pang; Tibor Schuster; Kristian B Filion; Mireille E Schnitzer; Maria Eberg; Robert W Platt
Journal:  Int J Biostat       Date:  2016-11-01       Impact factor: 0.968

9.  Evaluating Flexible Modeling of Continuous Covariates in Inverse-Weighted Estimators.

Authors:  Ryan P Kyle; Erica E M Moodie; Marina B Klein; Michał Abrahamowicz
Journal:  Am J Epidemiol       Date:  2019-06-01       Impact factor: 4.897

10.  simcausal R Package: Conducting Transparent and Reproducible Simulation Studies of Causal Effect Estimation with Complex Longitudinal Data.

Authors:  Oleg Sofrygin; Mark J van der Laan; Romain Neugebauer
Journal:  J Stat Softw       Date:  2017-10-16       Impact factor: 6.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.